Return to Work After Total Knee Arthroplasty in Young Patients

Return to Work After Total Knee Arthroplasty in Patients Under 55, a Retrospective Study in an University Hospital

This study takes its base in the augmenting number of primary total knee arthroplasty in the world whom quality and survey had permit to widen their indications to younger patients who are in the age of professional activity.

This work will focus on young patients under 55 who had had primary total knee arthroplasty, retrospectively, over the past 10 years, to determine the factors influencing early or late return to work, depending of socio economics factors.

This will optimize the information for the patient, and prepare him if necessary for a long work stop, and possibly obtain a better satisfaction for him.

Study Overview

• Status: Recruiting
• Conditions: Knee Arthritis
• Intervention / Treatment: Procedure: Total knee arthroplasty

Detailed Description

The primary aim of this study is to determine the rate of young patients returning to work after a primary total knee arthroplasty and the mean delay, and to compare it to other studies.

The mean delay of return to work in the literature is between 8 to 12 weeks, with up to 98% of patients returning to work.

The investigators will next determine which category of patients could have a late return to work superior to 6 months, and also if the surgery could give back a professional activity to patients who were in a long work stoppage.

• Study Type: Observational
• Enrollment (Anticipated): 200

Contacts and Locations

• Study Contact: Name: Didier MAINARD, PHD; Phone Number: 03 83 85 17 82; Email: didier.mainard@univ-lorraine.fr
• Study Contact Backup: Name: Alexandre COURAUDON; Phone Number: 03 83 85 17 82; Email: alexandre.couraudon@gmail.com

Study Locations

• France
  • Meurthe Et Moselle
    • Nancy, Meurthe Et Moselle, France, 54000
      • Recruiting
      • CHRU Nancy, Hopital central
      • Contact: Didier MAINARD, PHD; Phone Number: 03 83 85 17 82; Email: didier.mainard@univ-lorraine.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 55 years (ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients who underwent a total knee arthroplasty, under 55 at the time of surgery, with or without professional activity at the time of surgery

Description

Inclusion Criteria:

• first intention total knee arthroplasty
• Age at the time of surgery under 55

Exclusion Criteria:

• Not in capacity of completing a questionnaire
• revision of total knee arthroplasty

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
total knee arthroplasty under 55; Patient who had total knee arthroplasty before 55 between January 2010 and December 2019	Procedure: Total knee arthroplasty; First intention total knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Return to work in weeks	Duration between surgery and return to work	2 years

Collaborators and Investigators

• Sponsor: Central Hospital, Nancy, France
• Investigators: Principal Investigator: Didier MAINARD, PHD, CHRU Nancy

Publications and helpful links

Helpful Links

• return to work after total knee or hip arthroplasty

Study record dates

Study Major Dates

• Study Start (ACTUAL): July 20, 2022
• Primary Completion (ANTICIPATED): September 10, 2022
• Study Completion (ANTICIPATED): September 20, 2022

Study Registration Dates

• First Submitted: August 23, 2022
• First Submitted That Met QC Criteria: August 26, 2022
• First Posted (ACTUAL): August 30, 2022

Study Record Updates

• Last Update Posted (ACTUAL): August 30, 2022
• Last Update Submitted That Met QC Criteria: August 26, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Keywords: total knee arthroplasty; arthroplasty; return to work
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Arthritis
• Other Study ID Numbers: 2022-A00947-36

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No